Fountain Life, a preventative health and longevity insurance company, closed a $15 million funding round led by Eos Venture Partners.
Founded in 2020, the company looks to create a new kind of healthcare that is “predictive, preventive, personalized, and data-driven” by leveraging AI technology and diagnostic testing to identify conditions such as cancer, cardiac, metabolic, and neurodegenerative disease at the earliest stages.
Detecting asymptomatic disease is challenging because the human body is amazing at masking symptoms, but diagnostic technologies have come a long wayFountain Life CEO and co-founder, Bill Kapp
The ability to screen for structural abnormalities and other key indicators of developing disease exists today, but we must change the healthcare delivery model to truly realize the benefits of early disease detection.
The best way to avoid or mitigate long term issues is to look for them early – waiting until conditions manifest themselves and require costly treatment is suboptimal and can lead to reduced longevity and quality of life.
Fountain Health Insurance, a subsidiary of Fountain Life, covers traditional care, however, its primary focus is on proactive engagement and preventative care. The company is also led by life and business strategist Tony Robbins.